These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 23018784

  • 21. The impact of glucocorticoid therapy on trabecular bone score in older women.
    Paggiosi MA, Peel NF, Eastell R.
    Osteoporos Int; 2015 Jun; 26(6):1773-80. PubMed ID: 25743176
    [Abstract] [Full Text] [Related]

  • 22. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density.
    Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W.
    Bone; 2007 May; 40(5):1238-43. PubMed ID: 17347063
    [Abstract] [Full Text] [Related]

  • 23. Trabecular bone score of postmenopausal women is positively correlated with bone mineral density and negatively correlated with age and body mass index.
    Torgutalp ŞŞ, Babayeva N, Kara ÖS, Özkan Ö, Dönmez G, Korkusuz F.
    Menopause; 2019 Oct; 26(10):1166-1170. PubMed ID: 31188287
    [Abstract] [Full Text] [Related]

  • 24. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of trabecular bone score in patients with a distal radius fracture.
    Shin YH, Gong HS, Gang DH, Shin HS, Kim J, Baek GH.
    Osteoporos Int; 2016 Dec; 27(12):3559-3565. PubMed ID: 27341808
    [Abstract] [Full Text] [Related]

  • 26. Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial.
    Eastell R, Lang T, Boonen S, Cummings S, Delmas PD, Cauley JA, Horowitz Z, Kerzberg E, Bianchi G, Kendler D, Leung P, Man Z, Mesenbrink P, Eriksen EF, Black DM, HORIZON Pivotal Fracture Trial.
    Osteoporos Int; 2010 Jul; 21(7):1277-85. PubMed ID: 19802508
    [Abstract] [Full Text] [Related]

  • 27. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy.
    Israeli RS, Rosenberg SJ, Saltzstein DR, Gottesman JE, Goldstein HR, Hull GW, Tran DN, Warsi GM, Lacerna LV.
    Clin Genitourin Cancer; 2007 Mar; 5(4):271-7. PubMed ID: 17553207
    [Abstract] [Full Text] [Related]

  • 28. Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.
    Hans D, Shevroja E, McDermott M, Huang S, Kim M, McClung M.
    Osteoporos Int; 2022 Dec; 33(12):2517-2525. PubMed ID: 36115888
    [Abstract] [Full Text] [Related]

  • 29. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.
    Miller PD, Chines AA, Christiansen C, Hoeck HC, Kendler DL, Lewiecki EM, Woodson G, Levine AB, Constantine G, Delmas PD.
    J Bone Miner Res; 2008 Apr; 23(4):525-35. PubMed ID: 18072873
    [Abstract] [Full Text] [Related]

  • 30. Identification of rheumatoid arthritis patients with vertebral fractures using bone mineral density and trabecular bone score.
    Bréban S, Briot K, Kolta S, Paternotte S, Ghazi M, Fechtenbaum J, Roux C.
    J Clin Densitom; 2012 Apr; 15(3):260-6. PubMed ID: 22445857
    [Abstract] [Full Text] [Related]

  • 31. Trabecular bone score in healthy ageing.
    Bazzocchi A, Ponti F, Diano D, Amadori M, Albisinni U, Battista G, Guglielmi G.
    Br J Radiol; 2015 Aug; 88(1052):20140865. PubMed ID: 26148778
    [Abstract] [Full Text] [Related]

  • 32. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
    Huang S, Lin H, Zhu X, Chen X, Fan L, Liu C.
    Endokrynol Pol; 2014 Aug; 65(2):96-104. PubMed ID: 24802732
    [Abstract] [Full Text] [Related]

  • 33. TBS in early postmenopausal women with severe vertebral osteoporosis.
    Pouillès JM, Gosset A, Breteau A, Trémollieres FA.
    Bone; 2021 Jan; 142():115698. PubMed ID: 33091641
    [Abstract] [Full Text] [Related]

  • 34. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D.
    Osteoporos Int; 2018 Feb; 29(2):323-328. PubMed ID: 29167971
    [Abstract] [Full Text] [Related]

  • 35. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

  • 36. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [Abstract] [Full Text] [Related]

  • 37. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid.
    Gamsjaeger S, Buchinger B, Zwettler E, Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP.
    J Bone Miner Res; 2011 Jan; 26(1):12-8. PubMed ID: 20645415
    [Abstract] [Full Text] [Related]

  • 38. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
    Cauza E, Etemad M, Winkler F, Hanusch-Enserer U, Partsch G, Noske H, Dunky A.
    J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386
    [Abstract] [Full Text] [Related]

  • 39. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A, Glover SJ, Eastell R.
    Bone; 2009 Dec; 45(6):1044-52. PubMed ID: 19665601
    [Abstract] [Full Text] [Related]

  • 40. Effects of anti-resorptive agents on trabecular bone score (TBS) in older women.
    Krieg MA, Aubry-Rozier B, Hans D, Leslie WD, Manitoba Bone Density Program.
    Osteoporos Int; 2013 Mar; 24(3):1073-8. PubMed ID: 23052939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.